Prof. Ennio Tasciotti is head of the Human Longevity Program Laboratory at IRCCS San Raffaele. He graduated in Molecular Biology at Pisa Normal High School and achieved the PhD in Molecular Medicine at the International Center for Genetic Engineering & Biotechnology, a specialization in Molecular Imaging at AREA Science Park’s Molecular Biomedicine Consortium and a second specialization in. Nanomedicine At the University of Texas Health Science Center at Houston.
He was Chairman of the Department of Nanomedicine (2010-2015), founder and director of the Center for Biomimetic Medicine (2015-2020) at Houston Methodist Hospital, the best hospital in Texas and one of the top 20 hospitals in America.
Since 2010, it has raised more than $15 million in funding from the Department of Defense (DoD) and the Pentagon to create solutions to regenerate war wounds, $10 million from the National Institute of Health (NIH) to develop targeted therapies for cancer, $25 million in institutional support for the promotion of new scientific translational research programs for personalized medicine, regenerative medicine and digital medicine, and €1 million in funds from projects of the PNRR and the Italian Ministry of Health.
Prof. Tasciotti is considered one of the pioneers in the development of bio-inspired materials and nanotechnology for applications in targeted drug delivery, inflammation control and regenerative medicine approaches, has contributed 14 technical books, presented at more than 300 conferences and published 185 research articles (H-index: 50, more than 10,000 citations). His scientific work is at the intersection of engineering, pharmacology, biology and medicine. His discoveries are protected by 12 international patents on nanomaterials and biomaterials for biomedical use, some of which are licensed to private companies.